News From The American Chemical Society

Identifying abnormal protein levels in diabetic retinopathy

Researchers in Massachusetts are reporting an advance in bridging huge gaps in medical knowledge about the biochemical changes that occur inside the eyes of individuals with diabetic retinopathy (DR) – a leading cause of vision loss and blindness in adults. In a study scheduled for the June 6 issue of ACS’ monthly Journal of Proteome Research, they report discovery of 37 proteins that were increased or decreased in the eyes of patients with DR compared to patients without the disease.

Edward P. Feener and colleagues point out that DR is a complication of diabetes that affects the eyesight of millions of people. It involves damage to blood vessels in the retina, the light sensitive tissue in the back of the eye. Physicians know that vessels grow abnormally, swell, and leak in DR. However, they have little understanding of the biochemical changes underlying those damaging events.

The researchers studied eye fluid from individuals with and without DR who were undergoing eye surgery. They analyzed proteins in the vitreous, the gel-like material inside the eye between the retina and the lens. The study found 252 proteins in the fluid, including 37 proteins that showed changes that were associated with proliferative diabetic retinopathy, the most severe form of the disease. The study could lead to new insights into disease mechanisms and new treatments, the article states. – MTS

ARTICLE: “Characterization of the Vitreous Proteome in Diabetes without Diabetic Retinopathy and Diabetes with Proliferative Diabetic Retinopathy”

CONTACT:
Edward P. Feener, Ph.D.
Joslin Diabetes Center
Boston, Massachusetts 02215

“Super yeasts” produce 300 times more protein than previously possible

Researchers in California report development of a new kind of genetically modified yeast cell that produces complex proteins up to 300 times more than possible in the past. These “super yeasts” could help boost production and lower prices for a new generation of protein-based drugs that show promise for fighting diabetes, obesity, and other diseases, the researchers suggest. Their study is scheduled for the May 14 issue of the Journal of the American Chemical Society, a weekly publication.

In their report, Lei Wang and Qian Wang explain that the yeasts are intended for speeding production of proteins containing so-called “unnatural amino acids” (UAAs). Living things normally use the same basic set of 20 amino acids to make proteins. Scientists have made additional amino acids, the UAAs, which show promise for building new proteins with a broad range of medical and industrial applications. However, researchers had had difficulty in efficiently incorporating these UAAs into useful protein products.

Wang and Wang are reporting a solution to that problem. They inserted parts of the simple but highly efficient protein-making machinery of E. coli bacteria into the advanced but inefficient protein-making machinery of yeast cells. The result was a best-of-both world’s creation: A genetically-engineered yeast cell that produces complex proteins containing UAAs at levels 300 times higher than normal yeast cells. – MTS

ARTICLE: “New Methods Enabling Efficient Incorporation of Unnatural Amino Acids in Yeast”

CONTACT:
Lei Wang, Ph.D.
The Salk Institute for Biological Studies
La Jolla, California 92037

Consumers warm up to “greener” personal care products, but labeling controversy broils

From soaps to body lotions to shampoos, consumers are increasingly drawn to personal care products that are labeled “green” or environmentally-friendly, a fast-growing market that chalks-up an estimated $4 billion in sales per year worldwide. Despite the hype over these products, there’s growing confusion by consumers and manufacturers alike over what it really means to be labeled as “green,” according to an article scheduled for the May 12 issue of Chemical & Engineering News, ACS’ weekly newsmagazine.

C&EN Senior Correspondent Marc Reisch, the magazine’s cover story points out that there’s no universal consensus over what is green, organic, or sustainable. To the detriment of consumers, manufacturers sometimes produce misleading labels in an effort to cash-in on the hype, the article notes. Some manufacturers have even begun to certify their products as green under a variety of different standards and criteria or using different certifying bodies.

But change may be around the corner. Some groups in the U.S. and abroad are now working on establishing clearer standards for personal care products. Notes Reisch: “Unless ingredient makers and formulators sort out their differences, the subject of what is natural, organic, and sustainable may have to be sorted out in a court of law.”

ARTICLE: “Seeking Sustainability”

The American Chemical Society – the world’s largest scientific society – is a nonprofit organization chartered by the U.S. Congress and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.

Source: Michael Woods

American Chemical Society